What are the best treatments for CHARGE Syndrome?

TL;DR: There is no singular cure for CHARGE syndrome, so treatment focuses on a multidisciplinary, symptom-specific approach to manage the condition's complex clinical features. Care plans for CHARGE syndrome are highly individualized, prioritizing early surgical interventions for structural anomalies and long-term supportive therapies to improve quality of life.

How is CHARGE syndrome managed clinically?

Because CHARGE syndrome affects multiple organ systems, treatment is primarily supportive and reactive to the specific presentation of the patient. Management often begins in infancy with the stabilization of airway issues, such as choanal atresia, which requires urgent surgical repair. As CHARGE syndrome patients grow, the focus shifts to addressing hearing loss through cochlear implants or hearing aids, and visual impairments caused by coloboma, which requires regular monitoring by a pediatric ophthalmologist.

Which specialists should be on the care team?

Due to the complexity of CHARGE syndrome, care must be coordinated by a primary pediatrician or geneticist who facilitates communication between various specialists. A robust care team for CHARGE syndrome typically includes:

• Otolaryngologists (ENTs): To manage chronic ear infections and hearing loss.


• Cardiologists: To monitor and treat congenital heart defects, which occur in approximately 75-80% of cases.


• Speech-Language Pathologists: To address feeding difficulties and communication challenges.


• Physical and Occupational Therapists: To support motor skill development and address vestibular issues.


• Endocrinologists: To manage hypogonadism and growth hormone deficiencies.

Are there pharmacological or emerging treatments?

While no medication treats the underlying genetic cause of CHARGE syndrome, medications are used to manage complications. This may include hormone replacement therapy for hypogonadism or medications to manage gastroesophageal reflux. Currently, research into CHARGE syndrome is focused on gene-targeted therapies, though these remain in the preclinical stage; clinical trials are currently limited to observational studies and quality-of-life assessments.

How does treatment effectiveness vary?

The clinical expression of CHARGE syndrome is highly variable, meaning two individuals may require vastly different care pathways. The 122 members of the DiseaseMaps community with CHARGE syndrome highlight that early intervention—particularly in feeding and communication therapy—is the most consistent factor in improving long-term outcomes.

Next steps

• Consult a clinical geneticist to confirm the diagnosis and discuss the CHD7 gene mutation.


• Join the DiseaseMaps.org community to connect with other families managing CHARGE syndrome.


• Register with the CHARGE Syndrome Foundation for access to specialized provider directories.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; all treatment plans must be personalized by your child's primary medical team.

References

• NIH Genetic and Rare Diseases Information Center (GARD): CHARGE Syndrome Overview.


• Orphanet: Rare Disease Database (ORPHA:166).


• OMIM (Online Mendelian Inheritance in Man): Entry #214800 (CHARGE syndrome).


• CHARGE Syndrome Foundation: Clinical Guidelines for Management.